Eli Lilly announced plans to acquire three early and mid-stage vaccine developers — Curevo, LimmaTech Biologics, and Vaccine Company — for a combined $3.8 billion. Blackstone Life Sciences is ...

As hockey’s cultural footprint grows, the dental tech firm normalizes tooth loss and showcases its innovation.

After a guilty verdict for negligent homicide, a former nurse has found receptive audiences on the speaking circuit. She says ...

Congress' decision not to extend enhanced marketplace tax credits has boosted the appeal of alternative health coverage with ...

The risks and benefits of common screenings, procedures, and drugs add up differently at advanced ages, and research ...

Pharma brands are expected to have a large presence in the booths at ASCO this year. Here are the biggest themes marketers ...

The future of cholesterol-lowering drugs is nearing; CVS sues Tennessee over PBM law; Trump administration moves to ...

For years, point-of-care advertising aimed at healthcare providers has operated on a simple premise: get your message in front of clinicians while they’re somewhere near a patient. A waiting room ...

If he completes the lift, he’ll earn a $250,000 bonus for setting a world record. He grabs the bar, strains and…lets go, his ...

The deal adds pharmacy connectivity and adherence tools to Swoop’s platform, giving medical marketers a way to reach patients ...

Acting FDA chief proves popular among agency staffers; Eli Lilly’s gene editing tech sees early success; RFK Jr. offers legal ...